Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP190727.RAbxEpqUInyhldXG8KEoAiMPH6dEEdPAuL4gHmJj79Imk130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP190727.RAbxEpqUInyhldXG8KEoAiMPH6dEEdPAuL4gHmJj79Imk130_assertion type Assertion NP190727.RAbxEpqUInyhldXG8KEoAiMPH6dEEdPAuL4gHmJj79Imk130_head.
- NP190727.RAbxEpqUInyhldXG8KEoAiMPH6dEEdPAuL4gHmJj79Imk130_assertion description "[The two genes of the GAGE family that code for this peptide, namely GAGE-1 and GAGE-2, are expressed in a significant proportion of melanomas (24%), sarcomas (25%), non-small cell lung cancers (19%), head and neck tumors (19%), and bladder tumors (12%).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP190727.RAbxEpqUInyhldXG8KEoAiMPH6dEEdPAuL4gHmJj79Imk130_provenance.
- NP190727.RAbxEpqUInyhldXG8KEoAiMPH6dEEdPAuL4gHmJj79Imk130_assertion evidence source_evidence_literature NP190727.RAbxEpqUInyhldXG8KEoAiMPH6dEEdPAuL4gHmJj79Imk130_provenance.
- NP190727.RAbxEpqUInyhldXG8KEoAiMPH6dEEdPAuL4gHmJj79Imk130_assertion SIO_000772 7544395 NP190727.RAbxEpqUInyhldXG8KEoAiMPH6dEEdPAuL4gHmJj79Imk130_provenance.
- NP190727.RAbxEpqUInyhldXG8KEoAiMPH6dEEdPAuL4gHmJj79Imk130_assertion wasDerivedFrom befree-20140225 NP190727.RAbxEpqUInyhldXG8KEoAiMPH6dEEdPAuL4gHmJj79Imk130_provenance.
- NP190727.RAbxEpqUInyhldXG8KEoAiMPH6dEEdPAuL4gHmJj79Imk130_assertion wasGeneratedBy ECO_0000203 NP190727.RAbxEpqUInyhldXG8KEoAiMPH6dEEdPAuL4gHmJj79Imk130_provenance.